OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Biomarker ConsortiumInteractive ToolsLearning ModulesPresentationsSponsored
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
Advertisement

Multiple Myeloma: Emerging Concepts in Management

home / peer-exchange / mm6-management-concepts
Advertisement
Risk Assessment for Myeloma

EP. 1: Risk Assessment for Myeloma

January 23rd 2018
Managing High-Risk Smoldering Myeloma

EP. 2: Managing High-Risk Smoldering Myeloma

January 23rd 2018
Upfront Therapy Approaches in Myeloma

EP. 3: Upfront Therapy Approaches in Myeloma

January 23rd 2018
Upfront Combination Therapies in Myeloma

EP. 4: Upfront Combination Therapies in Myeloma

January 23rd 2018
Impact of Maintenance Therapy in Myeloma

EP. 5: Impact of Maintenance Therapy in Myeloma

January 23rd 2018
The Role of Transplant in Myeloma

EP. 6: The Role of Transplant in Myeloma

January 23rd 2018
Advertisement
Daratumumab-Based Regimens in R/R Myeloma

EP. 7: Daratumumab-Based Regimens in R/R Myeloma

January 23rd 2018
Impact of Elotuzumab in R/R Myeloma Therapies

EP. 8: Impact of Elotuzumab in R/R Myeloma Therapies

January 23rd 2018
Adding Carfilzomib to R/R Myeloma Regimens

EP. 9: Adding Carfilzomib to R/R Myeloma Regimens

January 23rd 2018
The Role of MRD Testing in Myeloma

EP. 10: The Role of MRD Testing in Myeloma

January 23rd 2018
Impact of MRD Assessment on Myeloma Treatment

EP. 11: Impact of MRD Assessment on Myeloma Treatment

January 23rd 2018
Other Agents for Treating Myeloma

EP. 12: Other Agents for Treating Myeloma

January 23rd 2018
Advertisement
Immunotherapies in Myeloma

EP. 13: Immunotherapies in Myeloma

January 23rd 2018
Improving Outcomes in Myeloma

EP. 14: Improving Outcomes in Myeloma

January 23rd 2018
Looking to the Future of Myeloma Care

EP. 15: Looking to the Future of Myeloma Care

January 23rd 2018

Latest Conference Coverage

Isa-KRd Elicits MRD-Negative Remissions in Newly Diagnosed, High-Risk Myeloma

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

Smoldering Multiple Myeloma Management Hinges on the Debate Between Treatment and Observation

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact